Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Jan 2026, Feb 2026 and Mar 2026.
- Largest single sale: $1.8M (42,841 shares) of Kiniksa Pharmaceuticals International, plc on Dec 8, 2025. Filing
- Last sale before this period: Aug 4, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chief Financial Officer | Dec 23, 2020 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 1, 2026, Kiniksa Pharmaceuticals International, plc: 9,104 shares vested; 4,404 shares withheld by the company for taxes. 1 filing: 1
- Apr 7, 2026, Kiniksa Pharmaceuticals International, plc: 2,694 shares vested; 1,303 shares withheld by the company for taxes. 1 filing: 1
- Apr 1, 2026, Kiniksa Pharmaceuticals International, plc: 5,187 shares vested; 2,510 shares withheld by the company for taxes. 1 filing: 1
- Mar 9, 2026, Kiniksa Pharmaceuticals International, plc: sold 36,722 shares for $1.7M, under a disclosed plan; 36,722 shares vested or acquired by exercising options. 1 filing: 1
- Feb 9, 2026, Kiniksa Pharmaceuticals International, plc: sold 17,845 shares for $772K, under a disclosed plan; 10,845 shares vested or acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.